학술논문

Analysis of ERBB2 (HER2) amplification by ctDNA in a phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DM1) with neratinib in women with metastatic disease with initially diagnosed HER2+breast cancer: NSABP FB-10
Document Type
Journal
Source
CANCER RESEARCH; FEB 2019, 79 4, 3p. Supplement: S
Subject
Language
English
ISSN
15387445